• SENSEX 73,257.62
    -341.05 (--0.46%)
  • BANKNIFTY 53,974.90
    -391.80 (--0.72%)
  • NSE
    1,766.00 1,640.25(%)
  • Reliance Industries
    1,161.90 1,152.30(%)
  • Piramal Pharma
    235.45 231.85(%)
  • Larsen & Toubro
    3,892.00 4,440.00(%)
  • Billionbrains
    189.95 227.00(%)
  • United Breweries
    1,316.00 1,845.90(%)
  • HDFC Bank
    687.15 1,017.90(%)
  • Lenskart Solut.
    697.50 725.00(%)
  • HDFC AMC
    2,317.50 2,901.00(%)
  • Cholaman.Inv.&Fn
    1,555.00 1,952.00(%)
  • Acutaas Chemical
    3,690.00 1,571.20(%)
  • Jubilant Ingrev.
    581.55 535.30(%)
  • One 97
    1,640.50 1,856.50(%)
  • Ola Electric
    37.44 51.84(%)
  • Sahajanand Medi
    482.10 347.50(%)
  • Bajaj Finance
    918.00 1,177.60(%)
  • Swiggy
    183.05 174.30(%)
  • Infosys
    1,103.50 980.30(%)
  • Patanjali Foods
    352.00 613.95(%)
  • Netweb Technol.
    4,490.00 5,810.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Amrutanjan Health Care Ltd Pharmaceuticals - Indian - Formulations

  • Amrutanjan
  • BSE Code : 17.0
  • ISIN : INE098F01031
489.50 0 (-0.05%)
  • As on 28 Oct 2026 (EOD)

  • Today’s Low

    487.40

  • Today’s High

    495.70

  • Open

    495.00

  • Perv Close

    489.75

  • 52W Low

    476.50

  • 52W High

    760.15

Key Indicators

  • P/E(TTM)

    22.79

  • Mar.Cap (₹Cr.)

    1,415.18

  • Div & Yield %

    1.00

  • Book Value(₹)

    128.06

  • Debt-Equity Ratio

    -0.05

  • AGM Date

    27-Oct-2026

  • EPS

    21.52

  • P/E Ratio

    22.79

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1,415.18

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    2.89

  • BV (₹)

    128.10

  • Sales( ₹ in Cr.)

    502.55

  • NP (in Cr.)

    64.18

  • NP Var(%)

    26.0

  • Div%

    490.0

  • CPS (₹)

    24.40

  • EPS (₹)

    22.20

  • Traded Value (₹ in Lakhs)

    1,417.92

  • 52 Week High

    760.15

  • 52 Week Low

    476.50

  • Price BSE

    490.0

  • Price NSE

    490.00

  • Market Capital( in Cr.)

    1,417.92

  • P/C Ratio

    20.10

  • P/E Ratio

    22.10

  • Price Vs.BV

    22.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 502.55 451.82 421.23 379.64 405.84 332.84
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 502.55 451.82 421.23 379.64 405.84 332.84
Other Income 17.57 17.68 16.35 14.54 15.38 11.32
Stock Adjustments 2.70 0.57 -2.15 1.73 5.50 -5.01
Total Income 522.82 470.07 435.43 395.91 426.72 339.15
EXPENDITURE :            
Raw Materials 247.06 223.78 209.67 183.71 185.96 135.18
Power and Fuel Cost 3.73 3.52 3.84 3.06 2.66 1.76
Employee Cost 63.76 59.10 47.69 48.81 48.23 41.70
Other Manufacturing Expenses 12.24 10.96 9.86 10.38 8.37 6.66
Selling and Administration Expenses 97.28 92.02 89.23 86.95 84.68 64.72
Miscellaneous Expenses 14.18 4.70 6.87 3.92 1.87 2.97
Employee Benefit Expenses 63.76 59.10 47.69 48.81 48.23 41.70
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 438.25 394.08 367.17 336.83 331.77 252.99
Operating Profit 84.58 75.99 68.25 59.08 94.95 86.16
Interest 0.37 0.33 0.25 0.22 0.58 0.59
Gross Profit 84.21 75.66 68.00 58.86 94.37 85.57
Depreciation 6.32 6.53 6.06 5.21 3.80 3.67
Profit Before Tax 77.89 69.13 61.94 53.65 90.57 81.90
Current Tax 22.13 17.97 15.94 14.01 23.39 19.73
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.16 0.33 1.03 -0.20 0.00 0.98
Reported Net Profit 57.92 50.83 44.97 39.83 67.19 61.19
Extraordinary Items -6.27 0.00 0.11 0.02 0.01 0.07
Adjusted Net Profit 64.19 50.83 44.86 39.81 67.18 61.12
Adjustment below Net Profit -0.14 -0.79 -35.32 0.00 0.00 0.00
P & L Balance brought forward 272.96 236.21 239.89 214.72 161.62 105.13
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 13.30 13.30 13.33 14.67 14.08 4.71
P & L Balance carried down 317.44 272.96 236.21 239.89 214.72 161.62
Dividend 0.00 0.00 0.00 0.00 5.85 4.68
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 490.00 460.00 460.00 460.00 460.00 420.00
Dividend Per Share(Rs) 4.90 4.60 4.60 4.60 4.60 4.20
Earnings Per Share-Unit Curr 20.03 17.58 15.56 13.63 22.99 20.93
Earnings Per Share(Adj)-Unit Curr 20.03 17.58 15.56 13.63 22.99 20.93
Book Value 128.06 112.97 99.78 99.47 90.70 73.75
Book Value(Adj)-Unit Curr 128.06 112.97 99.78 99.47 90.70 73.75

Shareholding Pattern

  • Promoter Group

    46.52%

  • Public Share Holding

    53.45%

  • Custodian

    0.04%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,825,803 20.15 5,825,803 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,529,487 8.75 2,529,487 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 5,092,900 17.62 5,092,900 3
Others 0 0.00 0 0
Sub Total 13,448,190 46.52 13,448,190 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 25,460 0.09 24,960 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,003,746 3.47 1,003,746 32
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,041,828 3.60 1,041,828 6
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 926,617 3.21 926,617 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,997,651 10.37 2,997,151 49
2] Non Institution
Bodies Corporate 510,014 1.76 509,494 183
Clearing Members 128 0.00 128 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 572,470 1.98 572,150 1,108
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 415,548 1.44 415,544 776
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,275,203 4.41 1,275,203 3
Individuals holding nominal share capital up to Rs. 1 lakh 8,995,704 31.12 8,610,978 44,026
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 436,940 1.51 436,940 2
Sub Total 12,454,240 43.08 12,068,670 46,129
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 10,549 0.04 10,549 1
Total Shares held by Custodians and against which Depository Receipts have been issued 10,549 0.04 10,549 1
Grand Total ( A + B + C ) 28,910,630 100.00 28,524,560 46,186

Company Background

Amrutanjan Health Care LtdPharmaceuticals - Indian - Formulations

  • Amrutanjan Health Care Ltd
  • BSE Code : 17.0
  • ISIN : INE098F01031

  • Incorporation Year

    1936

  • Registered Office

    New 103 Old 42-45 LuzChurch Rd
    Mylapore, Chennai,
    Tamil Nadu-600004

  • Telephone

    91-44-24994164/24994465/24994366

  • FAX

    91-44-24994585

  • Chairman

    S Sambhuprasad

  • Managing Director

    S Sambhuprasad

  • Company Secretary

  • Auditor

    B S R & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Amrutanjan Health Care Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Amrutanjan Healt 490.45 520.13 502.55 26.27 24.16
Abbott India 25,488.50 7,217.19 6,929.05 33.54 43.78
Astrazeneca Phar 6,073.10 2,304.07 2,275.58 89.51 27.86
Sanofi India 3,066.25 1,857.10 1,837.40 21.81 54.17
Glaxosmi. Pharma 2,488.75 3,932.76 3,790.20 39.76 58.17
Novartis India 1,847.40 393.10 354.33 46.65 15.94
Cipla 1,350.00 20,102.60 18,979.95 41.15 13.88
Bliss GVS Pharma 643.55 773.53 729.81 59.81 12.51
Fermenta Biotec. 449.00 474.15 450.25 20.96 18.77
Guj. Themis Bio. 352.45 168.25 165.82 94.24 18.05
Ambalal Sarabhai 35.40 19.52 3.94 65.56 6.77